Skip to main content
Top
Published in: Indian Journal of Surgical Oncology 1/2019

01-02-2019 | Metastasis | Original Article

Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication—a Retrospective Study by INDEPSO

Authors: Snita Sinukumar, Sanket Mehta, Dileep Damodaran, Firoz Rajan, Shabber Zaveri, Mukurdipi Ray, Ninad Katdare, Kayomarz Sethna, Mahesh D. Patel, Praveen Kammer, Abraham Peedicayil, Aditi Bhatt

Published in: Indian Journal of Surgical Oncology | Special Issue 1/2019

Login to get access

Abstract

To determine factors influencing failure-to-rescue in patients with complications following cytoreductive surgery and HIPEC. A retrospective analysis of patients enrolled in the Indian HIPEC registry was performed. Complications were graded according to the CTCAE classification version 4.3. The 30- and 90-day morbidity were both recorded. Three hundred seventy-eight patients undergoing CRS with/without HIPEC for peritoneal metastases from various primary sites, between January 2013 and December 2017 were included. The median PCI was 11 [range 0–39] and a CC-0/1 resection was achieved in 353 (93.5%). Grade 3–4 morbidity was seen 95 (25.1%) at 30 days and 122 (32.5%) at 90 days. The most common complications were pulmonary complications (6.8%), neutropenia (3.7%), systemic sepsis (3.4%), anastomotic leaks (1.5%), and spontaneous bowel perforations (1.3%). Twenty-five (6.6%) patients died within 90 days of surgery due to complications. The failure-to-rescue rate was 20.4%. Pulmonary complications (p = 0.03), systemic sepsis (p < 0.001), spontaneous bowel perforations (p < 0.001) and PCI > 20 (p = 0.002) increased the risk of failure-to-rescue. The independent predictors were spontaneous bowel perforation (p = 0.05) and systemic sepsis (p = 0.001) and PCI > 20 (p = 0.02). The primary tumor site did not have an impact on the FTR rate (p = 0.09) or on the grade 3–4 morbidity (p = 0.08). Nearly one-fifth of the patients who developed complications succumbed to them. Systemic sepsis, spontaneous bowel perforations, and pulmonary complications increased the risk of FTR and multidisciplinary teams should develop protocols to prevent, identify, and effectively treat such complications. All surgeons pursuing this specialty should perform a regular audit of their results, irrespective of their experience.
Appendix
Available only for authorised users
Literature
1.
go back to reference Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D, French Surgical Association (2010) Toward curative treatment of peritoneal carcinomatosis from non-ovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–5618CrossRefPubMed Glehen O, Gilly FN, Boutitie F, Bereder JM, Quenet F, Sideris L, Mansvelt B, Lorimier G, Msika S, Elias D, French Surgical Association (2010) Toward curative treatment of peritoneal carcinomatosis from non-ovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients. Cancer 116:5608–5618CrossRefPubMed
2.
go back to reference Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456CrossRefPubMed Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30:2449–2456CrossRefPubMed
3.
go back to reference Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Morice P, Pomel C, Pocard M, Guyon F, Porcheron J, Glehen O, FROGHI (FRench Oncologic and Gynecologic HIPEC) Group (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–1443CrossRef Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, Abboud K, Meeus P, Ferron G, Quenet F, Marchal F, Gouy S, Morice P, Pomel C, Pocard M, Guyon F, Porcheron J, Glehen O, FROGHI (FRench Oncologic and Gynecologic HIPEC) Group (2013) Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–1443CrossRef
4.
go back to reference Silber J, Romano P, Rosen A, Wang Y, Even-Shoshan O, Volpp K (2007) Failure-to-rescue: comparing definitions to measure quality of care. Med Care 45:918e925CrossRef Silber J, Romano P, Rosen A, Wang Y, Even-Shoshan O, Volpp K (2007) Failure-to-rescue: comparing definitions to measure quality of care. Med Care 45:918e925CrossRef
5.
go back to reference Silber JH, Williams SV, Krakauer H, Schwartz JS (1992) Hospital and patient characteristics associated with death after surgery: a study of adverse occurrence and failure to rescue. Med Care 30:615–629CrossRefPubMed Silber JH, Williams SV, Krakauer H, Schwartz JS (1992) Hospital and patient characteristics associated with death after surgery: a study of adverse occurrence and failure to rescue. Med Care 30:615–629CrossRefPubMed
7.
go back to reference Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard AC, Bakrin N, Cotte E, Gilly FN, Glehen O (2016) What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol 113(7):796–803. https://doi.org/10.1002/jso.24248 CrossRefPubMed Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard AC, Bakrin N, Cotte E, Gilly FN, Glehen O (2016) What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: a 25-year experience with 1,125 procedures. J Surg Oncol 113(7):796–803. https://​doi.​org/​10.​1002/​jso.​24248 CrossRefPubMed
9.
go back to reference Van der Speeten K, Lemoine L (2018) HIPEC methodology, comparison of techniques, and drug regimens: is there a need for standardization? In: Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Springer, pp 298–391 Van der Speeten K, Lemoine L (2018) HIPEC methodology, comparison of techniques, and drug regimens: is there a need for standardization? In: Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Springer, pp 298–391
10.
go back to reference Douchy T, Lemoine L, Van der Speeten K (2018) Early postoperative intraperitoneal chemotherapy: current role and future perspectives. In: Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Springer, pp 392–511 Douchy T, Lemoine L, Van der Speeten K (2018) Early postoperative intraperitoneal chemotherapy: current role and future perspectives. In: Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond. Springer, pp 392–511
13.
go back to reference Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Color Dis 17:772–778CrossRef Moran B, Cecil T, Chandrakumaran K, Arnold S, Mohamed F, Venkatasubramaniam A (2015) The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy. Color Dis 17:772–778CrossRef
14.
go back to reference Passot G, Vaudoyer D, Villeneuve L, Wallet F, Beaujard AC, Boschetti G, Rousset P, Bakrin N, Cotte E, Glehen O (2017) A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions. Ann Surg 265(4):806–813CrossRefPubMed Passot G, Vaudoyer D, Villeneuve L, Wallet F, Beaujard AC, Boschetti G, Rousset P, Bakrin N, Cotte E, Glehen O (2017) A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions. Ann Surg 265(4):806–813CrossRefPubMed
16.
go back to reference Kim B, Alzharani N, Valle S, Liauw W, Morris D (2017) Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Peritoneum (and other serosal surfaces) 2:65CrossRef Kim B, Alzharani N, Valle S, Liauw W, Morris D (2017) Treatment-related post-operative mortality after cytoreductive surgery and perioperative intraperitoneal chemotherapy. J Peritoneum (and other serosal surfaces) 2:65CrossRef
17.
go back to reference Gupta V, Singla N, Gombar S, Palta S, Chander J (2018) Prevalence of multidrug-resistant pathogens and their antibiotic susceptibility pattern from late-onset ventilator-associated pneumonia patients from a tertiary-care hospital in North India. J Assoc Chest Phys 6:4–11CrossRef Gupta V, Singla N, Gombar S, Palta S, Chander J (2018) Prevalence of multidrug-resistant pathogens and their antibiotic susceptibility pattern from late-onset ventilator-associated pneumonia patients from a tertiary-care hospital in North India. J Assoc Chest Phys 6:4–11CrossRef
19.
go back to reference Chéreau E, Ballester M, Selle F, Cortez A, Pomel C, Darai E, Rouzier R (2009) Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer. Int J Obstet Gynaecol 116(8):1062–1068CrossRef Chéreau E, Ballester M, Selle F, Cortez A, Pomel C, Darai E, Rouzier R (2009) Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer. Int J Obstet Gynaecol 116(8):1062–1068CrossRef
20.
go back to reference Franssen B, Tabrizian P, Weinberg A, Romanoff A, Tuvin D, Labow D, Sarpel U (2015) Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol 22:1639–1644CrossRefPubMed Franssen B, Tabrizian P, Weinberg A, Romanoff A, Tuvin D, Labow D, Sarpel U (2015) Outcome of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on patients with diaphragmatic involvement. Ann Surg Oncol 22:1639–1644CrossRefPubMed
21.
go back to reference Gouda J, Prusty RK (2014) Overweight and obesity among women by economic stratum in urban India. J Health Popul Nutr 32(1):79–88PubMedPubMedCentral Gouda J, Prusty RK (2014) Overweight and obesity among women by economic stratum in urban India. J Health Popul Nutr 32(1):79–88PubMedPubMedCentral
22.
go back to reference Pradeepa R, Anjana RM, Joshi SR, Bhansali A, Deepa M, Joshi PP, Dhandania VK, Madhu SV, Rao PV, Geetha L, Subashini R, Unnikrishnan R, Shukla DK, Kaur T, Mohan V, Das AK, ICMR-INDIAB Collaborative Study Group (2015) Prevalence of generalized & abdominal obesity in urban & rural India--the ICMR-INDIAB study (phase-I) [ICMR- NDIAB-3]. Indian J Med Res 142(2):139–150CrossRefPubMedPubMedCentral Pradeepa R, Anjana RM, Joshi SR, Bhansali A, Deepa M, Joshi PP, Dhandania VK, Madhu SV, Rao PV, Geetha L, Subashini R, Unnikrishnan R, Shukla DK, Kaur T, Mohan V, Das AK, ICMR-INDIAB Collaborative Study Group (2015) Prevalence of generalized & abdominal obesity in urban & rural India--the ICMR-INDIAB study (phase-I) [ICMR- NDIAB-3]. Indian J Med Res 142(2):139–150CrossRefPubMedPubMedCentral
23.
go back to reference Alyami M, Lundberg P, Kepenekian V, Goéré D, Bereder JM, Msika S, Lorimier G et al (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study. Ann Surg Oncol 23(Suppl 5):737–745CrossRefPubMed Alyami M, Lundberg P, Kepenekian V, Goéré D, Bereder JM, Msika S, Lorimier G et al (2016) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study. Ann Surg Oncol 23(Suppl 5):737–745CrossRefPubMed
24.
go back to reference Kammar P, Waghoo S, Anam J, Agarwal A, Borkar N, Mehta S, et al (2018) Utility of bipap (biphasic positive airway pressure) ventilation in crs+hipec (cytoreductive surgery+ hyperthermic intraperiotneal chemotherapy). Pleura and Peritoneum; 1, Special Suppl, pp sA6–sA463, September 2018 (page sA123) Kammar P, Waghoo S, Anam J, Agarwal A, Borkar N, Mehta S, et al (2018) Utility of bipap (biphasic positive airway pressure) ventilation in crs+hipec (cytoreductive surgery+ hyperthermic intraperiotneal chemotherapy). Pleura and Peritoneum; 1, Special Suppl, pp sA6–sA463, September 2018 (page sA123)
25.
go back to reference McPartland SJ, Goodman MD (2014) The effect of elevated body mass index on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 21:1463–1467CrossRefPubMed McPartland SJ, Goodman MD (2014) The effect of elevated body mass index on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 21:1463–1467CrossRefPubMed
26.
go back to reference Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA (2013) Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intra- peritoneal chemotherapy for appendiceal and colon primary tumours. Ann Surg Oncol 20:3899–3904CrossRefPubMedPubMedCentral Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, Levine EA (2013) Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intra- peritoneal chemotherapy for appendiceal and colon primary tumours. Ann Surg Oncol 20:3899–3904CrossRefPubMedPubMedCentral
27.
go back to reference Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M (2012) Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 256:334–341CrossRefPubMed Baratti D, Kusamura S, Mingrone E, Balestra MR, Laterza B, Deraco M (2012) Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 256:334–341CrossRefPubMed
28.
go back to reference Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, Bartlett DL (2008) Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol 15(11):3065–3072CrossRefPubMed Franko J, Gusani NJ, Holtzman MP, Ahrendt SA, Jones HL, Zeh HJ, Bartlett DL (2008) Multivisceral resection does not affect morbidity and survival after cytoreductive surgery and chemoperfusion for carcinomatosis from colorectal cancer. Ann Surg Oncol 15(11):3065–3072CrossRefPubMed
29.
go back to reference Johnston M, Arora S, Anderson O, King D, Behar N, Darzi A (2015) Escalation of care in surgery: a systematic risk assessment to prevent avoidable harm in hospitalized patients. Ann Surg 261:831–838CrossRefPubMed Johnston M, Arora S, Anderson O, King D, Behar N, Darzi A (2015) Escalation of care in surgery: a systematic risk assessment to prevent avoidable harm in hospitalized patients. Ann Surg 261:831–838CrossRefPubMed
30.
go back to reference Johnston MJ, Arora S, King D, Bouras G, Almoudaris AM, Davis R, Darzi A (2015) A systematic review to identify the factors that affect failure to rescue and escalation of care in surgery. Surgery 157:752–763CrossRefPubMed Johnston MJ, Arora S, King D, Bouras G, Almoudaris AM, Davis R, Darzi A (2015) A systematic review to identify the factors that affect failure to rescue and escalation of care in surgery. Surgery 157:752–763CrossRefPubMed
32.
go back to reference Youkan R, Kamara S, Buratti D et al (2008) Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98:253–257CrossRef Youkan R, Kamara S, Buratti D et al (2008) Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 98:253–257CrossRef
33.
go back to reference Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G (2018) Ninety-day post-operative morbidity and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth 34(5):532–537. https://doi.org/10.1080/02656736.2017.1367846 CrossRef Alyami M, Kim BJ, Villeneuve L, Vaudoyer D, Képénékian V, Bakrin N, Gilly FN, Cotte E, Glehen O, Passot G (2018) Ninety-day post-operative morbidity and mortality using the National Cancer Institute’s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperth 34(5):532–537. https://​doi.​org/​10.​1080/​02656736.​2017.​1367846 CrossRef
Metadata
Title
Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication—a Retrospective Study by INDEPSO
Authors
Snita Sinukumar
Sanket Mehta
Dileep Damodaran
Firoz Rajan
Shabber Zaveri
Mukurdipi Ray
Ninad Katdare
Kayomarz Sethna
Mahesh D. Patel
Praveen Kammer
Abraham Peedicayil
Aditi Bhatt
Publication date
01-02-2019
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue Special Issue 1/2019
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-019-00877-x

Other articles of this Special Issue 1/2019

Indian Journal of Surgical Oncology 1/2019 Go to the issue